HERE'S something not to be sneezed at. A vaccine against grass pollen, which can cause hay fever, has been shown as safe and effective in a trial of 180 patients. If larger trials are a success, a vaccine could be available within four years.
Hay fever is caused by the immune system's immunoglobulin E (IgE) antibodies reacting excessively to pollen. Therapy to prevent this reaction typically builds up immunity by injecting regular small doses of pollen over several years.
To offer faster relief, Biomay, a firm in Vienna, Austria, has developed a shot that combines part of a pollen molecule with a hepatitis B protein. The IgE antibodies still get activated, but the protein mobilises other antibodies, which block the IgE ones. This prevents an excessive immune response. Just four injections over a few months should be required, says Angela Neubauer of Biomay.
Another hay fever vaccine, made by Allergy Therapeutics in Worthing, UK, is about to re-enter trials after research was put on hold for five years while severe side effects in one patient were investigated.
This article appeared in print under the headline "Quick injections blow hay fever away"
- New Scientist
- Not just a website!
- Subscribe to New Scientist and get:
- New Scientist magazine delivered every week
- Unlimited online access to articles from over 500 back issues
- Subscribe Now and Save
If you would like to reuse any content from New Scientist, either in print or online, please contact the syndication department first for permission. New Scientist does not own rights to photos, but there are a variety of licensing options available for use of articles and graphics we own the copyright to.
